Stan Berenshteyn Analyst PerformanceEquity Research Analyst, Digital Health at Wells Fargo & CompanyStan Berenshteyn is a stock analyst at Wells Fargo & Company focused in the medical sector, covering 13 publicly traded companies. Over the past year, Stan Berenshteyn has issued 36 stock ratings, including buy and hold recommendations. While full access to Stan Berenshteyn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Stan Berenshteyn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings46 Last 4 YearsBuy Recommendations64.44% 29 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution45RatingsDistribution of strong buy, buy, hold, and sell ratings by Stan Berenshteyn.RatingPercentageCount Strong Buy0.0%0 ratings Buy64.4%29 ratings Hold35.6%16 ratings Sell0.0%0 ratingsOut of 45 total stock ratings issued by Stan Berenshteyn at Wells Fargo & Company, the majority (64.4%) have been Buy recommendations, followed by 35.6% Hold.Best & Worst CallsBest Call000.0%OMCLMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%HCATJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE53.8% of companies on NYSE7 companiesNASDAQ46.2% of companies on NASDAQ6 companiesStan Berenshteyn, an analyst at Wells Fargo & Company, currently covers 13 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical11 companies84.6%Services1 company7.7%Computer and Technology1 company7.7%Stan Berenshteyn of Wells Fargo & Company specializes in stock coverage within the Medical sector, with additional focus on Services and Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL INFO SYS6 companies46.2%MEDICAL SERVICES4 companies30.8%SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING1 company7.7%BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED1 company7.7%INTERNET SOFTWARE1 company7.7% Stan Berenshteyn's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsDOCSDoximity5/14/2026Reiterated Rating$23.52$18.00Equal Weight$0.0000.00% ROIDOCSDoximity5/14/2026Downgrade$17.94Hold$0.0000.00% ROIDOCSDoximity5/11/2026Lower Price Target$25.97$32.00Overweight$0.0000.00% ROIOMDAOmada Health5/8/2026Boost Price Target$16.40$18.00Equal Weight$0.0000.00% ROIHNGEHinge Health5/6/2026Boost Price Target$54.22$80.00Overweight$0.0000.00% ROIOMCLOmnicell4/23/2026Boost Price Target$36.34$55.00Overweight$0.0000.00% ROIPHRPhreesia3/26/2026Lower Price Target$11.75$25.00Overweight$0.0000.00% ROICTEVClaritev3/19/2026Lower Price Target$16.31$22.00Equal Weight$0.0000.00% ROIHCATHealth Catalyst3/18/2026Reiterated Rating$1.17$1.00Equal Weight$0.0000.00% ROIVEEVVeeva Systems3/5/2026Lower Price Target$193.49$317.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. GDRXGoodRx3/4/2026Lower Price Target$2.14$3.50Overweight$0.0000.00% ROITDOCTeladoc Health2/26/2026Lower Price Target$5.18$6.00Equal Weight$0.0000.00% ROICTEVClaritev2/24/2026Set Price Target$23.10$30.00Equal Weight$0.0000.00% ROIWAYWaystar2/19/2026Lower Price Target$25.41$36.00Overweight$0.0000.00% ROIDOCSDoximity2/6/2026Lower Price Target$33.30$45.00Overweight$0.0000.00% ROIDOCSDoximity1/20/2026Upgrade$41.25$55.00Overweight$0.0000.00% ROIPHRPhreesia1/8/2026Initiated Coverage$16.88$30.00Overweight$0.0000.00% ROIHNGEHinge Health1/8/2026Initiated Coverage$49.40$68.00Overweight$0.0000.00% ROIWAYWaystar1/8/2026Initiated Coverage$33.08$41.00Overweight$0.0000.00% ROICTEVClaritev1/8/2026Set Price Target$31.16$33.00Equal Weight$0.0000.00% ROIOMDAOmada Health1/8/2026Initiated Coverage$16.44$17.00Equal Weight$0.0000.00% ROIHNGEHinge Health1/8/2026Initiated Coverage$48.01$68.00Overweight$0.0000.00% ROIOMDAOmada Health1/8/2026Upgrade$15.41Hold$0.0000.00% ROIPHRPhreesia1/8/2026Initiated Coverage$17.24$30.00Overweight$0.0000.00% ROIWAYWaystar1/8/2026Initiated Coverage$34.50$41.00Overweight$0.0000.00% ROICTEVClaritev1/8/2026Upgrade$32.04Hold$0.0000.00% ROIOMCLOmnicell1/5/2026Boost Price Target$45.14$52.00Overweight$0.0000.00% ROIVEEVVeeva Systems11/25/2025Lower Price Target$236.10$333.00Overweight$0.0000.00% ROIHCATHealth Catalyst11/11/2025Lower Price Target$2.66$5.00Overweight$0.0000.00% ROIAMWLAmerican Well11/5/2025Lower Price Target$4.78$9.00Overweight$0.0000.00% ROIVEEVVeeva Systems8/26/2025Boost Price Target$285.54$326.00Overweight$0.0000.00% ROIHCATHealth Catalyst8/11/2025Lower Price Target$2.57$6.00Overweight$0.0000.00% ROIAMWLAmerican Well8/7/2025Lower Price Target$7.50$12.00Overweight$0.0000.00% ROIDOCSDoximity8/4/2025Boost Price Target$58.54$62.00Equal Weight$0.0000.00% ROIOMCLOmnicell7/21/2025Boost Price Target$27.82$40.00Overweight$0.0000.00% ROIVEEVVeeva Systems5/29/2025Boost Price Target$281.19$300.00Overweight$0.0000.00% ROIOMCLOmnicell5/14/2025Upgrade$28.00$35.00Overweight$00.0000.00% ROITDOCTeladoc Health5/8/2025Lower Price Target$6.90$8.00Equal Weight$0.0000.00% ROIOMCLOmnicell5/7/2025Lower Price Target$25.42$31.00Equal Weight$00.0000.00% ROIGDRXGoodRx4/29/2025Lower Price Target$4.60$7.00Overweight$0.0000.00% ROII was right about SpaceX (Ad)Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.See how to claim your stake in SpaceX before the public canOMCLOmnicell4/17/2025Lower Price Target$30.17$38.00Equal Weight$00.0000.00% ROIGDRXGoodRx2/28/2025Lower Price Target$4.85$8.00Overweight$0.0000.00% ROIHQYHealthEquity2/26/2025Boost Price Target$107.45$125.00Overweight$00.0000.00% ROIHCATHealth Catalyst1/21/2025Lower Price Target$5.88$10.00Overweight$0.0000.00% ROIOMCLOmnicell1/13/2025Lower Price Target$42.25$40.00Equal Weight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
